R. D. de Real

Elevated HLA-E and NKG2A as a Consequence of Chronic Immune Activation Defines Resistance to M. bovis BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer

O. Elemento, R. Sebra, H. Ravichandran, 2022, bioRxiv.

NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.

M. Skobe, R. Sebra, M. Galsky, 2022, Cancer cell.

NKG2A and HLA-E define a novel alternative immune checkpoint axis in bladder cancer

Brian H. Lee, M. Carrington, M. Skobe, 2022, bioRxiv.